Absci Corporation
USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Absci ranks #25,631 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.
- #25,631
- of 49,997 US assignees by volume
- Top 13%
- by Innovation Score (50.6/100)
- 20.6
- avg claims per patent
- +250%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R25631 · US Corporation #25,631 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #25,631/49,997
- PHOTO-FINISH AB7 Innovation S U
- CPC-NARROW C07K · 8 areas
- INNOV-PAR 50.6/100
- CLAIMS-DENSE 20.6 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +250% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: AB7 Innovation S.A.S.U. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Absci’s 50.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Absci
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Absci · this assignee
Absci · this assignee
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Absci's Innovation Score is 50.6/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Absci?
Each dot is one of Absci’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Absci’s own 20.6 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Absci's grants concentrate
Absci Corporation is a focused PatentsView assignee: 8 CPC subclasses with 90% of grants classified under C07K (Peptides). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2017. By volume, Absci sits between AB7 Innovation S.A.S.U. and Acea Therapeutics, Inc..
Absci's three-year grant acceleration
Absci Corporation shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Absci's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- AB7 Innovation S U
AB7 Innovation S.A.S.U.
10 patents
- Abatement
Abatement Technologies, Inc.
10 patents
- Abengoa BioenergÍ…
Abengoa BIOENERGÍA Nuevas TECHNOLOGÍAS, S.A.
10 patents
- ABI Anlagentechni…
ABI Anlagentechnik-Baumaschinen-Industriebedarf Maschinenfabrik und Vertriebsgesellschaft mbH
10 patents
- Absolics
Absolics Inc.
10 patents
- Acciona Energia
Acciona Energia S.A.
10 patents
- Accord Ideation P…
Accord Ideation Private Limited
10 patents
- Acea Therapeutics
Acea Therapeutics, Inc.
10 patents
- Absci ◀
Absci Corporation
10 patents
What this shows Absci holds 10 patents at rank #25,631, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Absci
By rank, the assignees closest to #25,631 in granted patent volume.
- AB7 Innovation S.A.S.U. #25,627 · 10 patents
- Abatement Technologies, Inc. #25,628 · 10 patents
- Abengoa BIOENERGÍA Nuevas TECHNOLOGÍAS, S.A. #25,629 · 10 patents
- ABI Anlagentechnik-Baumaschinen-Industriebedarf Maschinenfabrik und Vertriebsgesellschaft mbH #25,630 · 10 patents
- Absolics Inc. #25,632 · 10 patents
- Acciona Energia S.A. #25,633 · 10 patents
- Accord Ideation Private Limited #25,634 · 10 patents
- Acea Therapeutics, Inc. #25,635 · 10 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Absci's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Absci's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 13% higher than 87% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2020 | 1 | 10.0% |
| 2022 | 3 | 30.0% |
| 2023 | 1 | 10.0% |
| 2024 | 2 | 20.0% |
| 2025partial year | 1 | 10.0% |
Which technologies does Absci Corporation patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Absci Corporation's patent record in context - here's where to go next.
- Absci Corporation's lead technology class is C07K (Peptides), 90% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #25,631 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Absci Corporation against AB7 Innovation S.A.S.U., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.